Resveratrol-downregulated phosphorylated liver kinase B1 is involved in senescence of acute myeloid leukemia stem cells

Dan-yue Peng , Hui Song , Ling-bo Liu

Current Medical Science ›› 2015, Vol. 35 ›› Issue (4) : 485 -489.

PDF
Current Medical Science ›› 2015, Vol. 35 ›› Issue (4) : 485 -489. DOI: 10.1007/s11596-015-1457-7
Article

Resveratrol-downregulated phosphorylated liver kinase B1 is involved in senescence of acute myeloid leukemia stem cells

Author information +
History +
PDF

Abstract

Senescence is an important obstacle to cancer development. Engaging a senescent response may be an effective way to cure acute myeloid leukemia (AML). The aim of this study was to examine the effect of resveratrol-downregulated phosphorylated liver kinase B1 (pLKB1) on the senescence of acute myeloid leukemia (AML) stem cells. The protein expressions of pLKB1 and Sirtuin 1 (SIRT1), a regulator of pLKB1, were measured in CD34+CD38 KG1a cells treated with resveratrol (40 μmol/L) or not by Western blotting. Senescence-related factors were examined, including p21 mRNA tested by real-time PCR, cell morphology by senescence-associated β-galactosidase (SA-β-gal) staining, cell proliferation by MTT assay and cell cycle by flow cytometry. Besides, apoptosis was flow cytometrically determined. The results showed that pLKB1 was highly expressed in CD34+CD38 KG1a cells, and resveratrol, which could downregulate pLKB1 through activation of SIRT1, induced senescence and apoptosis of CD34+CD38 KG1a cells. It was concluded that resveratrol-downregulated pLKB1 is involved in the senescence of AML stem cells.

Keywords

phosphorylated liver kinase B1 (pLKB1) / Sirtuin 1 (SIRT1) / resveratrol / acute myeloid leukemia (AML) / leukemia stem cells (LSCs) / cellular senescence

Cite this article

Download citation ▾
Dan-yue Peng, Hui Song, Ling-bo Liu. Resveratrol-downregulated phosphorylated liver kinase B1 is involved in senescence of acute myeloid leukemia stem cells. Current Medical Science, 2015, 35(4): 485-489 DOI:10.1007/s11596-015-1457-7

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

WangJ. Current status of leukemia stem cells study. Chin J Hematol, 2011, 32(6): 361-362

[2]

StyczynskiJ, DrewaT. Leukemia stem cells: from metabolic pathways and signaling to a new concept of drug resistance targeting. Acta Biochim pol, 2007, 54(4): 717-726 PMID: 18080019

[3]

KonoplevaMY, JordanCT. Leukemia stem cells and microenvironment: biology and therapeutic targeting. J Clin Oncol, 2011, 29(5): 591-599 PMID: 21220598

[4]

HayflickL, MoorheadPS. The serial cultivation of human diploid cell strains. Exp Cell Res, 1961, 25: 585-621 PMID: 13905658

[5]

XiaoY, WangJ, SongH, et al. . CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence. Leuk Res, 2013, 37(3): 333-340 PMID: 23219618

[6]

JenneDE, ReimannH, NezuJ, et al. . Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet, 1998, 18(1): 38-43 PMID: 9425897

[7]

HardieDG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev, 2011, 25(18): 1895-1908 PMCID: 3185962 PMID: 21937710

[8]

RowanA, BatailleV, MacKieR, et al. . Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. J Invest Dermatol, 1999, 112(4): 509-511 PMID: 10201537

[9]

KarumanP, GozaniO, OdzeRD, et al. . The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell, 2001, 7(6): 1307-1319 PMID: 11430832

[10]

AlessiDR, SakamotoK, BayascasJR. LKB1-dependent signaling pathways. Annu Rev Biochem, 2006, 75: 137-163 PMID: 16756488

[11]

TiainenM, VaahtomeriK, YlikorkalaA, et al. . Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1). Hum Mol Genet, 2002, 11(13): 1497-1504 PMID: 12045203

[12]

ZuY, LiuL, LeeMY, et al. . SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res, 2010, 106(8): 1384-1393 PMID: 20203304

[13]

GanB, HuJ, JiangS, et al. . Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature, 2010, 468(7324): 701-704 PMCID: 3058342 PMID: 21124456

[14]

GurumurthyS, XieSZ, AlagesanB, et al. . The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature, 2010, 468(7324): 659-663 PMCID: 3037591 PMID: 21124451

[15]

NakadaD, SaundersTL, MorrisonSJ. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature, 2010, 468(7324): 653-658 PMCID: 3059717 PMID: 21124450

[16]

OtaH, TokunagaE, ChangK, et al. . Sirt1 inhibitor, sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene, 2006, 25(2): 176-185 PMID: 16170353

[17]

BradamanteS, BarenghiL, VillaA. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev, 2004, 22(3): 169-188 PMID: 15492766

[18]

MortonJP, JamiesonNB, KarimSA, et al. . LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest. Gastroenterology, 2010, 139(2): 586-597 PMCID: 3770904 PMID: 20452353

[19]

ColladoM, BlascoMA, SerranoM. Cellular senescence in cancer and aging. Cell, 2007, 130(2): 223-233 PMID: 17662938

[20]

ColladoM, GilJ, EfeyanA, et al. . Tumor biology: senescence in premalignant tumours. Nature, 2005, 436(7051): 642 PMID: 16079833

[21]

RowanA, BatailleV, MacKieR, et al. . Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. J Invest Dermatol, 1999, 112(4): 509-511 PMID: 10201537

[22]

WangY, LiuL, PazhanisamySK, et al. . Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radic Biol Med, 2010, 48(2): 348-356 PMCID: 2818724 PMID: 19925862

[23]

WangY, LiuL, ZhouD. Inhibition of p38 MAPK attenuates ionizing radiation-induced hematopoietic cell senescence and residual bone marrow injury. Radiat Res, 2011, 176(6): 743-752 PMCID: 3390189 PMID: 22014293

[24]

WangY, KellnerJ, LiuL, et al. . Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion. Stem Cells Dev, 2011, 20(7): 1143-1152 PMCID: 3121934 PMID: 21198398

[25]

ZouJ, ZouP, WangJ, et al. . Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells. Ann Hematol, 2012, 91(6): 813-823 PMCID: 3390192 PMID: 22258328

[26]

BourdeauV, FerbeyreG. Engaging a senescent response to cure leukemia. Nat Med, 2014, 20(2): 123-124 PMID: 24504403

[27]

AblainJ, RiceK, SoilihiH, et al. . Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure. Nat Med, 2014, 20(2): 167-174 PMID: 24412926

AI Summary AI Mindmap
PDF

89

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/